0
Signin
countryflagUS

18889881171

AAPL 190.415 0.3663% MSFT 422.65 -0.1016% GOOG 175.36 0.8512% GOOGL 174.14 0.9449% AMZN 185.71 -0.1505% NVDA 943.46 -0.3001% META 473.555 -1.6582% TSLA 174.87 0.5058% TSM 154.06 -0.977% LLY 776.1758 -1.3779% V 280.145 -0.2972% AVGO 1436.4972 0.0228% JPM 204.205 1.0366% UNH 522.225 0.9033% NVO 133.03 -1.2105% WMT 63.485 6.109% LVMUY 170.79 -0.2511% XOM 117.87 -0.5988% LVMHF 855.728 -0.1473% MA 461.6867 0.805%

GeneDx Holdings Corp.

Healthcare US WGS

23.1USD
1.94(9.17%)

Last update at 2024-05-16T16:52:00Z

Day Range

21.5023.18
LowHigh

52 Week Range

1.1617.91
LowHigh

Financials

Income Statement

Balancesheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Type yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Income before tax -598.03200M -245.39000M -241.34000M -29.70400M
Minority interest - - - -
Net income -548.98000M -245.39000M -246.43600M -30.99100M
Selling general administrative 203.33M 205.99M 100.74M 29.48M
Selling and marketing expenses 134.91M 112.74M 63.18M 39.35M
Gross profit -26.75000M -16.60200M 4.03M 82.78M
Reconciled depreciation 59.31M 21.81M 11.73M 6.41M
Ebit -667.65200M -446.14900M -241.99400M -30.41300M
Ebitda -395.60000M -424.34200M -227.13200M -22.51400M
Depreciation and amortization 272.05M 21.81M 14.86M 7.90M
Non operating income net other 72.83M - - -
Operating income -667.65200M -446.14900M -241.99400M -30.41300M
Other operating expenses 692.20M 658.34M 421.32M 226.59M
Interest expense 3.21M 2.83M 2.47M 0.78M
Tax provision -49.05200M 0.00000M 0.00000M 0.00000M
Interest income 2.54M 0.08M 0.51M 0.99M
Net interest income -0.66600M -2.75600M -1.96800M 0.20M
Extraordinary items - - - -
Non recurring 210.15M - - -
Other items - - - -
Income tax expense -49.05200M -203.59400M 5.10M 1.29M
Total revenue 234.69M 212.19M 179.32M 196.17M
Total operating expenses 430.76M 429.55M 246.02M 113.20M
Cost of revenue 261.44M 228.80M 175.30M 113.39M
Total other income expense net 69.62M 200.76M 0.65M 0.71M
Discontinued operations - - - -
Net income from continuing ops -548.98000M -245.39000M -241.34000M -29.70400M
Net income applicable to common shares -548.98000M -245.39000M -241.34000M -32.74300M
Preferred stock and other adjustments - - - -
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Type yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Total assets 490.94M 554.09M 251.64M -
Intangible assets 186.65M - - -
Earning assets - - - -
Other current assets 6.39M 3.80M 4.12M 0.90M
Total liab 237.24M 165.99M 581.69M -
Total stockholder equity 253.71M 388.10M -330.05100M -
Deferred long term liab 2.66M - - 0.20M
Other current liab 92.12M 52.70M 39.65M 3.06M
Common stock 0.04M 0.02M - -
Capital stock 0.04M 0.02M 0.00000M -
Retained earnings -1124.42100M -575.44100M -330.05100M -88.71100M
Other liab 26.68M 53.71M 134.06M 12.97M
Good will - - - -
Other assets 7.38M 7.83M 14.42M 4.77M
Cash 123.93M 400.57M 108.13M -
Cash and equivalents - - - -
Total current liabilities 144.30M 101.28M 73.44M 40.19M
Current deferred revenue 0.04M 0.47M 1.78M -
Net debt -51.54900M -367.72300M -63.10700M -
Short term debt 6.12M 3.42M 5.28M -
Short long term debt 4.75M - 1.77M -
Short long term debt total 72.38M 32.85M 45.02M -
Other stockholder equity 1378.09M 963.52M - -
Property plant equipment 84.28M 62.72M 63.11M 35.26M
Total current assets 212.62M 483.54M 174.11M 163.81M
Long term investments - - - -
Net tangible assets 253.71M 388.10M -330.05100M -88.71100M
Short term investments - - - -
Net receivables 43.34M 26.56M 32.33M 21.64M
Long term debt 6.25M 11.00M 18.97M -
Inventory 13.66M 33.46M 24.96M 15.98M
Accounts payable 46.02M 44.69M 26.74M 17.48M
Total permanent equity - - - -
Noncontrolling interest in consolidated entity - - - -
Temporary equity redeemable noncontrolling interests - - - -
Accumulated other comprehensive income - - - -
Additional paid in capital - - - -
Common stock total equity 0.04M - - -
Preferred stock total equity - - - -
Retained earnings total equity -1124.42100M - - -
Treasury stock - - - -
Accumulated amortization - - - -
Non currrent assets other 7.38M 7.83M 14.42M -
Deferred long term asset charges - - - -
Non current assets total 278.32M 70.55M 77.53M -
Capital lease obligations 66.13M 21.85M 24.28M -
Long term debt total 6.25M - - -
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Type yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Investments -141.32600M -20.78600M -31.97400M -15.45600M
Change to liabilities 14.99M 24.61M 14.25M 15.19M
Total cashflows from investing activities -141.32600M -20.78600M -31.97400M -15.45600M
Net borrowings -3.29200M -13.46900M 11.73M -1.70900M
Total cash from financing activities 197.31M 493.73M 129.06M 148.01M
Change to operating activities -8.02200M -11.43900M 19.19M -3.38900M
Net income -548.98000M -245.39000M -241.34000M -29.70400M
Change in cash -263.16600M 282.51M 3.95M 113.83M
Begin period cash flow 401.47M 118.96M 115.01M 1.18M
End period cash flow 138.30M 401.47M 118.96M 115.01M
Total cash from operating activities -319.15500M -190.43400M -93.12800M -18.72800M
Issuance of capital stock 0.00000M 442.68M 117.32M 118.82M
Depreciation 59.31M 21.81M 11.73M 6.41M
Other cashflows from investing activities -134.17000M - - -
Dividends paid - - - -
Change to inventory 4.60M -10.62400M -8.97900M -7.97000M
Change to account receivables 5.53M 5.54M -10.61100M -4.56700M
Sale purchase of stock 200.61M - - -
Other cashflows from financing activities 200.61M 64.51M 133.25M 149.72M
Change to netincome 133.89M 25.00M 122.63M 5.31M
Capital expenditures 14.32M 20.79M 31.97M 15.46M
Change receivables 5.53M - - -
Cash flows other operating 13.24M - - -
Exchange rate changes - - - -
Cash and cash equivalents changes -263.16600M - - -
Change in working capital 36.13M 8.08M 13.85M -0.73700M
Stock based compensation 41.98M 219.42M 120.23M 5.48M
Other non cash items 141.53M 1.62M 2.40M -0.17600M
Free cash flow -333.47700M -211.22000M -125.10200M -34.18400M

Fundamentals

  • Previous Close 21.16
  • Market Cap74.87M
  • Volume210640
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-220.53101M
  • Revenue TTM206.50M
  • Revenue Per Share TTM9.95
  • Gross Profit TTM -26.75000M
  • Diluted EPS TTM-35.44

Peer Comparison

Sector: Healthcare Industry: Health Information Services

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
WGS
GeneDx Holdings Corp.		 1.94 9.17% 23.10 - - 0.33 0.26 0.13 -0.0778
GEHC
GE HealthCare Technologies Inc.		 -0.02 0.02% 81.89 22.39 17.33 1.78 4.79 2.18 11.79
VEEV
Veeva Systems Inc Class A		 -0.365 0.17% 211.01 54.61 33.22 12.83 6.73 11.14 58.84
MTHRF
M3 Inc		 -0.84 7.20% 10.83 29.72 25.00 0.05 4.38 0.04 0.12
MTHRY
M3 Inc		 -0.1016 1.90% 5.25 31.84 26.25 0.05 4.60 0.04 0.12

Reports Covered

Stock Research & News

View All

Disclaimer - Data Powered by EOD Historical Data (“EODHD”). All CFDs (stocks, indices, mutual funds, ETFs), and Forex are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. EODHD is not using exchanges data feeds for the pricing data, EODHD is using OTC, peer to peer trades and trading platforms over 100+ sources, EODHD is aggregating its data feeds via VWAP method. Therefore, EOD Historical Data doesn’t bear any responsibility for any trading losses you might incur as a result of using this data. EOD Historical Data or anyone involved with EOD Historical Data will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible. EOD Historical Data does not give any warranties (including, without limitation, as to merchantability or fitness for a particular purpose or use).